The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients. [electronic resource]
Producer: 20140509Description: 2959-64 p. digitalISSN:- 1532-1827
- Anastrozole
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Cell Differentiation -- physiology
- Cell Growth Processes -- physiology
- Clinical Trials, Phase III as Topic
- Female
- Gene Expression Profiling
- Humans
- Neoplasm Metastasis
- Neoplasm Recurrence, Local -- drug therapy
- Nitriles -- administration & dosage
- Prognosis
- Proportional Hazards Models
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2 -- biosynthesis
- Receptors, Estrogen -- biosynthesis
- Retrospective Studies
- Signal Transduction
- Tamoxifen -- administration & dosage
- Treatment Outcome
- Triazoles -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.